Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 3/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | F7 | P08709 | 2/20 | 0.40 |
| ▸ | F3 | P13726 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8694153 | 1.00 | LTA4H (0.50) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL8694155 | 1.00 | LTA4H (0.50) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL1716729 | 1.00 | LTA4H (0.50) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL1716727 | 1.00 | LTA4H (0.50) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL21595289 | 0.98 | LTA4H (0.52) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL21595291 | 0.98 | LTA4H (0.52) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL7253734 | 0.92 | CYP1A2 (0.50) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL7253732 | 0.92 | CYP1A2 (0.50) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL414072 | 0.90 | ACE2 (0.52) | LTA4HACE2CYP1A2BLMGABRR1 | |
| SCHEMBL31189197 | 0.90 | ALDH1A1 (0.47) | LTA4HBLMFFAR1FFAR4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011554-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | Givaudan, S.A. (CH) | 2018-07-03 | — | — | US | disclosed |
| US-20170327452-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN S.A. (CH) | 2017-11-16 | — | — | US | disclosed |
| US-9745245-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | GIVAUDAN S.A. (CH) | 2017-08-29 | — | — | US | disclosed |
| EP-2370391-B1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN SA (CH) | 2014-02-12 | — | — | EP | disclosed |
| US-20110263725-A1 | Alpha-branched Alkenoic Acids and the Use of Alpha-branched Alkanoic and Alkenoic Acids as a Fragrance | GIVAUDAN SA (CH) | 2011-10-27 | — | — | US | disclosed |
| EP-2370391-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | Givaudan SA (CH) | 2011-10-05 | — | — | EP | disclosed |
| WO-2010063133-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN SA (CH) | 2010-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011554-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | FASN, ELOVL1, ACOX1 | LTA4H 46/4885ACE2 1809/4885CYP1A2 206/4885 |
| US-20110263725-A1 | Alpha-branched Alkenoic Acids and the Use of Alpha-branched Alkanoic and Alkenoic Acids as a Fragrance | FASN, ELOVL1, ACOX1 | LTA4H 46/4885ACE2 1809/4885CYP1A2 206/4885 |
| US-20170327452-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | FASN, ELOVL1, ACOX1 | LTA4H 46/4885ACE2 1809/4885CYP1A2 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.